Nutra Pharma Corp.
NPHC
$0.00
$0.00100.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.30M | -1.32M | -1.23M | -1.39M | 2.08M |
| Total Depreciation and Amortization | 89.60K | 91.60K | 93.60K | 95.60K | 122.80K |
| Total Amortization of Deferred Charges | 131.90K | 124.70K | 116.80K | 142.60K | 253.60K |
| Total Other Non-Cash Items | 235.60K | 205.40K | 166.60K | 263.40K | -4.13M |
| Change in Net Operating Assets | 408.90K | 358.90K | 222.40K | 341.80K | 1.26M |
| Cash from Operations | -431.90K | -535.20K | -628.40K | -550.00K | -417.80K |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | 83.60K | 83.60K | 83.60K | 83.60K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.00K | 32.50K | 23.70K | 33.70K | 85.20K |
| Cash from Investing | 116.60K | 116.10K | 107.30K | 117.30K | 85.20K |
| Total Debt Issued | 832.00K | 930.60K | 1.01M | 909.00K | 1.02M |
| Total Debt Repaid | -516.60K | -511.40K | -491.00K | -476.20K | -682.30K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 315.30K | 419.10K | 521.20K | 432.80K | 332.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -- | 0.00 |